Malaria is the most significant parasitic disease affecting humans, with 212 25 million cases and 429,000 deaths in 2015 1 , and resistance to existing drugs endangers 26 the global malaria elimination campaign. Atovaquone (ATO) is a safe and potent 27 antimalarial drug that acts on cytochrome b (cyt. b) of the mitochondrial electron 28 transport chain (mtETC) in Plasmodium falciparum, yet treatment failures result in 29 resistance-conferring SNPs in cyt. b. Herein we report that rather than the expected de 30 novo selection of resistance, previously unknown mitochondrial diversity is the genetic 31 mechanism responsible for resistance to ATO, and potentially other cyt. b targeted 32 drugs. We found that P. falciparum harbors cryptic cyt. b. Y268S alleles in the multi-33 copy (~22 copies) mitochondrial genome prior to drug treatment, a phenomenon known 34 as mitochondrial heteroplasmy. Parasites with cryptic Y268S alleles readily evolve into 35 highly resistant parasites with >95% Y268S copies under in vitro ATO selection. Further 36 we uncovered high mitochondrial diversity in a global collection of 1279 genomes in 37 which heteroplasmic polymorphisms were >3-fold more prevalent than homoplasmic 38 SNPs. Moreover, significantly higher mitochondrial genome copy number was found in 39
yielded intriguing results on the role of heteroplasmy and mitochondrial copy number. 162 DSM1 drug selections with ATO resistant TM90-C2B were not successful at 10x EC 50 163
(1.5 uM) concentrations, with three failed attempts (Extended Data Figure 4 ). Using 164 lower DSM1 concentrations (2x EC 50 = 300 nM) made resistance development possible. 165
Deep-sequencing of C2B+10xDSM1 selected lines (Figure 2A ) revealed that parasites 166 thawed from earliest cryopreserved line and expanded for sequencing (45 days of total 167 DSM1 exposure) largely lost their initial resistance to ATO during DSM1 exposure, with 168 parasites gradually exchanging their Y268S allele in favor of copy number amplifications 169 in DHODH, implying that these resistance mechanisms are antagonistic at low 170 concentrations of DSM1, but completely incompatible at high concentrations. The initial 171 ability to survive both DSM1 and atovaquone pressure could consist of immediate 172 reactions to respirational stress, where DSM1 induces DHODH amplifications quickly 173 and proportionately to DSM1 exposure, and Y268S is cryptically present and able to 174 increase allele numbers at any time. Both of these mechanisms are attractive from the 175 metabolic standpoint in that they are readily adaptable and can be appropriately tuned 176 for maximum fitness. Similarly, the increased mitochondrial copy number observed with 177 some selections (e.g, ARC08-88; Figure 2C ) could contribute to an enhanced stress 178 response and high-grade resistance phenotype. The initial phenotypic response and 179 resultant fading high-grade ATO/DSM1 resistance seen in ATO, MEN, and DSM1 180 selections can all be attributed to a combination of these genetic plasticity features, 181 leading to metabolic plasticity with clear advantages for the parasite. 182
We next sought to estimate the worldwide frequency and distribution of 183 mitochondrial heteroplasmy. We analyzed the publicly available P. falciparum data fromthe MalariaGEN Pf3k project (www.malariagen.net/pf3k) 28 to uncover heteroplasmic 185 mitochondrial diversity globally. After removing samples of multiple infections, lab lines, 186 duplicates, and progenies of genetic crosses, we calculated the copy number of 187 mitochondria number Ĉ of 1279 genomes using the sequencing depth differences 188 between nuclear genome and mitochondrial genomes, with sampling-computation 189 based correction of the sequencing coverage bias impacted by GC content without taking heteroplasmy into account. Geographically-specific polymorphisms exist 207 in both homoplasmic and heteroplasmic SNPs ( Figure 3B ), suggesting important 208 phenotypes might be associated with heteroplasmy. Interestingly, Cambodian P. 209 falciparum isolates had a much higher rate of heteroplasmic SNPs than isolates from 210 Ghana ( Figure 3B ). In addition, the mitochondrial copy number varied geographically 211 with the highest copy numbers found in SE Asia where antimalarial drug resistance 212 repeatedly emerges ( Figure 3C ). In agreement with widespread heteroplasmy in the 213 global population, our study of deep-sequencing Asian parasite collections also 214 revealed heteroplasmy, with Y268S as a low frequency common allele ( Figure 2A & 215
3E). 216
Finally, to provide physical evidence of Y268S heteroplasmy, we performed 217 single molecule sequencing with Nanopore 33 on mtDNA of TM90-C2B. We obtained 218 >500x coverage of mitochondrial genome and longest reads of >20 kb ( Figures 3F and  219 3G). The single molecule sequencing resulted in the same levels of allele count with 220 NGS sequencing with 90% Y268S in both systems ( Figure 3H ). Single reads consisting 221 of both Y268S and references alleles were detected, thus supporting the heteroplasmy 222 genetics of ATO resistance and mitochondrial diversity ( Figure 3H) . . Regardless, our data suggest heteroplasmy is 228 transmitted and maintained as shown in the population diversity data, since both 229 homoplasmic and heteroplasmic SNPs could be seen circulating in local populations( Figure 3B ). Conceivably, heteroplasmy allows both neutral polymorphisms and alleles 231 with fitness costs to be maintained at low frequencies and successfully transmitted. 232
Additional fitness studies are required to further assess the transmission potential of the 233 Y268S mutants with high copies of the mutant allele. The mechanism by which low-level 234 diversity is maintained in organisms with similar mt-DNA structure/replication strategies 235 has been studied extensively and is known as substoichiometric shifting. In plants, 236 substoichiometric shifting produces unique subgenomic mitochondrial DNA molecules 237 as the result of a recombination-based replication strategy, and can confer fitness 238 advantages. It is unknown whether substoichiometric shifting can explain the 239 maintenance of subgenomic mtDNA variants in Plasmodium, but it warrants further 240
investigation. 241
In this study we provide multiple lines of evidence that mitochondrial 242 heteroplasmy is the genetic mechanism underlying ATO resistance. These include in 243 vitro drug selection, ATO resistance phenotype analysis, clinical isolate 244 characterization, pyrosequencing analysis, mitochondrial copy number, and single 245 molecule sequencing. Although current polymorphism studies represent a conservative 246 estimate of heteroplasmy and mitochondrial copy numbers, our population analysis 247
shows intriguing mitochondrial diversity exists in SE Asia, where resistance first 248 emerged for many antimalarial drugs. Furthermore, increased mitochondrial copy 249 number was observed in the same region, and also in parasites exposed to drug 250 selection pressure in vitro. Our study revealed two novel aspects of malarial parasite 251 mitochondrial genetics, i.e, heteroplasmy and copy number variations related to ATO 252 resistance; these results will be crucial for developing other mitochondrial-targeting All P. falciparum cytochrome b PCR products were amplified using primers cytbFOR 314 5'-TGCCTAGACGTATTCCTG-3' and cytbREV 5'-GAAGCATCCATCTACAGC-3'. 315
PCRs were amplified using Phusion HS II High-Fidelity PCR Master Mix (ThermoFisher 316 Scientific) with ~20 ng parasite gDNA template, according to manufacturer's instructions 317 with the following program: 98°C-30s initial denaturation step, then 35 cycles: (98°C-318 10s, 54°C-40s, 72°C-30s) and a final extension of 72°C for 7 min. PCR products 319 were confirmed as a single, discrete band of 1,382 bp length on a 1% agarose gel then 320 subsequently purified using the Qiagen PCR Purification Kit according to manufacturer's 321
instructions. Purified PCR products were prepared for Sanger sequencing service atGenewiz (Genewiz, South Plainfield, NJ) using the following sequencing primers: pf-323 cytb-SEQFOR1: 5'-GTGGAGGATATACTGTGAGTG-3', pf-cytb-SEQFOR2: 5'-324 TACAGCTCCCAAGCAAAC-3', pf-cytb-SEQREV1: 5'-325 GACATAACCAACGAAAGCAG-3', and pf-cytb-SEQREV2: 5'-326 GTTCCGCTCAATACTCAG-3'. The dhodh gene was sequenced similarly using 327 primers described in Ross et al 19 . Sample sequences were analyzed and aligned using 328 ApE (A Plasmid Editor) software, and mapped to the Pf-3D7 cytochrome b gene 329 annotated on Plasmodb.org for mutation detection. 330
Sequencing to identify SNPs in mitochondrial genes. We sequenced multiple 331 candidate genes in the mtETC to determine if additional SNPs were associated with the 332 drug resistance spectrum phenotypes. All PCR reactions were set up similarly to the 333 sequencing of the cytochrome b gene above. Candidate genes included 334 PF3D7_0915000 (NDH2), PF3D7_0603300 (DHODH), PF3D7_0523100 (Core 1), 335 PF3D7_093360 (Core 2), PF3D7_1462700 (cyt. c 1 ), PF3D7_1439400 (Rieske), 336 PF3D7_1426900 (QCR6), PF3D7_1012300 (QCR7), and the three mt-encoded genes: 337
MAL_MITO_3 (cyt. b), MAL_MITO_1 (coxIII), MAL_MITO_2 (coxI). For the primers in 338
Extended Data Table 5 , those labeled PCR FOR and PCR REV were used in PCR 339 amplifications, and SEQ PR denotes primers used to sequence the amplification in its 340
entirety. 341

Pyrosequencing of Y268S allele. 342
The Pyromark Q96 ID system was used for the detection of single-nucleotide 343
polymorphism (SNP) for Y268S detection in Pf-cytochrome b, with Qiagen Pyromark 344
Gold Q96 reagents and buffers along with streptavidin sepharose beads (GEHealthcare). All template and reaction components were prepared according to 346 manufacturer's protocols. Pyrosequencing primers were designed using Pyromark 347 Assay Design Software. Primers for the initial PCR reaction were amplified with 348
PFcytb_pyro_Biotin_FOR 5'-Biotin-ACCATGGGGTCAAATGAGTTAT-3' and 349
PFcytb_pyro_REV 5 Pyromark ID software in allele quantification mode.
Pyrosequencing Y268S assay standard curve. Since all Y268S mutant genotypes 369
still contained some small quantities of wild-type allele, we chose to use the parasite 370 with the highest percentage Y268S mutant, TM90-C50B5 gDNA (99.52% mutant) and 371 D6 (0% mutant) were mixed at 10% increments from 0% wild type gDNA + 100% wild 372 type gDNA, adding in additional increment mixtures at the lower 5% and upper 95%, 373 with 1% increments to look at the sensitivity of detection. These ratio wild type:mutant 374 gDNA mixtures were made independently three times and then used in subsequent 375 PCR reactions and pyrosequencing reactions to generate the standard curve in Figure  376 1A. 377
DHODH Copy Number Variation Quantitative PCR (qPCR). Pf-DHODH copy number 378
was determined using the DHODH qPCR primers previously described by Guler et al. vitro selected parasite genomes, we ran samples on the Illumina HiSeq 3000 with the 385 150 cycle protocol (PCR-free) and used >1 ug purified DNA as starting material, and 386 reached 10,000-30,000 x coverage of mtDNA. Each allele must have a minimum of 100 387 high quality reads (QC score > 60) mapped to the loci to be identified as a rare allele. 388
As controls, we examined all loci with the same stringency, and our method did not 389 recover any low frequency heteroplasmy in the vast majority of the loci (n=5954), other 390 than a few loci including Y268S. 391
For computational mining of the sites with heteroplasmy in the global parasite 392 populations, we developed a maximum likelihood based method to differentiate high 393 confidence heteroplasmic sites from background error count. We use a statistical 394 measurement of maximum likelihood (PL score) of SNP detection based on VCF 395 (variant call format) output in GATK pipeline 32 to detect allele frequency (AF). First, we 396 obtained the genotype likelihood (GL) for the given loci, with GL defined as LOG10 397 scaled likelihoods for all possible genotypes given the set of alleles defined in the REF 398
and ALT fields, as specified by GATK protocols 40, 41 . Then, the phred-scaled genotype 399 likelihood (PL) score is obtained. Only the PL score of being heteroplasmic vs being 400 homoplasmic, at a given locus, larger than 6 (i.e, Pvalue < 0.000001), is considered a 401 true heteroplasmic site. The lower AF value indicates lower level of heteroplasmy, while 402 AF = 1 indicates homoplasmy, either wild type or mutants. 403
To independently confirm our computational mining methods, we examined 100 404
isolates from the population data sets. We retrieved the raw data mitochondrial BAM 405 files, and examined that the heteroplasmic sites are correctly identified by the maximum 406 likelihood method, as shown by more than a hundred high quality reads in the mapping 407
alignments. 408
We used the sequencing depth differences to estimate the copy number of query 409 chromosome from sequencing signal. Here, we assume the PCR amplification level is 410 same for each chromosome copy. It has been reported the copy number of nuclear 411 chromosome is 1 during asexual stage in Plasmodium
30
. Therefore, the sequencing 412 depth difference between input and reference nuclear chromosome is the estimated 413 copy number of query chromosome (equation 1).
(1) 415
where is the estimated copy number and is the estimated sequencing signal. To 416 find the best estimation of sequencing signal, we assume that the true sequencing 417 reads signal of a whole specific chromosome follows a uniform distribution. Then we 418 calculated the optimal sequencing depth with 419
(2) 421
Here, i(n = i ∑ ) is a given segment on the chromosome; and the sequencing signal r i is 422 calculated as 423
where R i is the total reads mapped on segment i, L i is the segment length. The final 425 estimation from equation 2 is 426 427 Nanopore mtDNA sequencing. 428
Isolation of mitochondrial DNA in TM90-C2B 429
Parasites were grown to 10% parasitemia in 50 mL culture volume, then 430 synchronized with 5% sorbitol twice, spaced 4 hours apart, followed by MACS column 431 purification to remove any residual trophozoites and schizonts so that only ring stages 432 were collected to obtain non-replicative mtDNA molecule forms only. Red blood cellswere then lysed using 0.1% saponin in 1x PBS, washed 3x in PBS, and mitochondrial 434 DNA was isolated from parasite material using the Abcam Mitochondrial DNA Isolation 435
Kit using the manufacturer's instructions, with the exception of using needle passage to 436 
Data Analysis 466
Nanopore sequencing reads were processed using the Metrichor cloud platform 467 2D workflow. Only the reads (Fast5 files) that passed Metrichor quality cutoffs were 468 converted into fastq format using poretools (v0.5) 42 . The reads were aligned against the 469 Plasmodium falciparum 3D7 (PlasmoDB v28) 43 reference genome using the BWA-MEM 470 (v0.7.15) 44 with settings "-x ont2d". The aligned data was used to generate a .bam file 471 using SAMtools (v1.3.1) 45 and BCFtools (v1.3.1). Finally, alignments were visually 472 inspected using IGV viewer 46 in an attempt to trace back the % Y268S mutation in the 473 parasite. Extended Data Table 3 .
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